SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-204326
Filing Date
2013-05-07
Accepted
2013-05-07 15:52:09
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d503680d10q.htm 10-Q 487451
2 EX-31.1 d503680dex311.htm EX-31.1 6772
3 EX-31.2 d503680dex312.htm EX-31.2 7233
4 EX-32.1 d503680dex321.htm EX-32.1 3007
5 EX-32.2 d503680dex322.htm EX-32.2 3103
  Complete submission text file 0001193125-13-204326.txt   3453227

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20130331.xml EX-101.INS 400924
7 XBRL TAXONOMY EXTENSION SCHEMA infi-20130331.xsd EX-101.SCH 41344
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE infi-20130331_cal.xml EX-101.CAL 51127
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE infi-20130331_def.xml EX-101.DEF 207717
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20130331_lab.xml EX-101.LAB 306123
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20130331_pre.xml EX-101.PRE 240989
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 13819832
SIC: 2834 Pharmaceutical Preparations